Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001477449-24-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-04 | TDOC | Geshuri Arnnon | CHRO | S - Sale+OE | $14.52 | -6,108 | 38.5K | -14% | -$88.7K |
| DM | 2024-03-05 | 2024-03-01 | TDOC | Geshuri Arnnon | CHRO | M - OptEx | — | +16.6K | 29.2K | +131% | — |
| DM | 2024-03-05 | 2024-03-01 | TDOC | Geshuri Arnnon | CHRO | M - OptEx | $0.00 | -16.6K | 4,717 | -78% | $0 |
| D | 2024-03-05 | 2024-03-01 | TDOC | Geshuri Arnnon | CHRO | A - Grant | $0.00 | +11.7K | 11.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | S | D | 6,108 | $14.52 | 38,470 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 2 | Common | Common Stock | 2024-03-01 | M | A | 3,909 | — | 44,578 | D | — | — | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-03-01 | M | A | 11,470 | — | 40,669 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-03-01 | M | A | 1,179 | — | 29,199 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Derivative | Performance Stock Units | 2024-03-01 | M | D | 3,909 | $0.00 | 7,819 | D | — · — to — | 3,909 Common Stock | (F2) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F9) On March 1, 2024, the reporting person earned 11,728 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Performance Stock Units | 2024-03-01 | A | A | 11,728 | $0.00 | 11,728 | D | — · — to — | 11,728 Common Stock | (F7) Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. (F6) Each performance stock unit represents a contingent right to receive one share of TDOC common stock. (F8) The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-03-01 | M | D | 11,470 | $0.00 | 22,942 | D | — · — to — | 11,470 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 3, 2023, the reporting person was granted 34,412 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2024-03-01 | M | D | 1,179 | $0.00 | 4,717 | D | — · — to — | 1,179 Common Stock | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |